Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases
Open accessThe DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Most of our current knowledge about cellular phenotypes in neurodevelopmental and neurodegenerative diseases in humans was gathered from studies in postmortem brain tissues. These samples often represent the end-stage of the disease and therefore are not always a fair representation of how the disease developed. Moreover, under these circumstances, the pathology observed could be a secondary effect rather than the authentic disease cellular phenotype. Likewise, the rodent models available do not always recapitulate the pathology from human diseases. In this review, we will examine recent literature on the use of induced pluripotent stem cells to model neurodegenerative and neurodevelopmental diseases. We highlight the characteristics of diseases like spinal muscular atrophy and familial dysautonomia that allowed partial modeling of the disease phenotype. We review human stem cell literature on common neurodegenerative late-onset diseases such as Parkinson's disease and amyotrophic lateral sclerosis where patients' cells have been successfully reprogrammed but a disease phenotype has not yet been described. So far, the technique is of great interest for early onset monogenetic neurodevelopmental diseases. We speculate about potential further experimental requirements and settings for reprogrammed neurons for in vitro disease modeling and drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · cited 1×
“Yamanaka’s original reprogramming experiment surprised the scientific community by overturning the dogma that specialized cells in the body retain an immutable identity (1).”
BackgroundEmbryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1529 · Cited by 3,620 · cited 1×
“They include co-culture systems [such as mesencephalic astrocytes (16) and stromal cell-derived inducing activity (17)] and direct differentiation protocols (18).”
BackgroundDirect conversion of fibroblasts to functional neurons by defined factors
Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Südhof, T. C., & Wernig, M. (2010) · Nature · doi:10.1038/nature08797 · Cited by 3,017 · cited 1×
“Technology is already available to generate functionally active, cortical-like mouse neurons from differentiated cells without the need for complete reprogramming to iPSC (45,46).”
BackgroundHuman induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196 · cited 3×
“Huntington’s disease Not shown (3) Rett syndrome”
BackgroundDimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962
MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y. (2008) · Science · doi:10.1126/science.1153252 · Cited by 1,823
Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins
Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.04.005 · Cited by 1,788
Cited by
Items 101–168 of 168
Disease Modeling of Neurodegenerative Disorders Using Direct Neural Reprogramming
Legault, E. M., Bouquety, J., & Drouin‐Ouellet, J. (2022) · Cellular Reprogramming · doi:10.1089/cell.2021.0172 · Cited by 7
Growth and Neurotrophic Factor Receptors in Neural Differentiation and Phenotype Specification
Glaser, T., Oliveira‐Giacomelli, Á., Sardà‐Arroyo, L., & Ulrich, H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800781-5.00007-4 · Cited by 7
Human iPSC Models in Drug Discovery: Opportunities and Challenges
Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J. (2017) · Comprehensive Medicinal Chemistry III · doi:10.1016/b978-0-12-409547-2.12284-x · Cited by 6
Modeling of Menkes disease via human induced pluripotent stem cells
Suh, J.-H., Kim, D.-K., Kim, H., Helfman, D. M., Choi, J., Lee, B. H., Yoo, H., & Han, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.038 · Cited by 6
Exploiting the potential of next-generation sequencing in genomic medicine
Pinto, A. M., Ariani, F., Bianciardi, L., Daga, S., & Renieri, A. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1224181 · Cited by 5
Li, R., Bai, Y., Liu, T., Wang, X., & Wu, Q. (2013) · Protein & Cell · doi:10.1007/s13238-013-2089-y · Cited by 5
Sajadian, A., Jafarian, M., Khodaie, B., Sadeghi, S. M., & Ghaemi, A. (2014) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.2.2.56 · Cited by 5
Pirrotte, P., Yuan, Y., Hansen, N. P., Vasquez, I., Jiang, N., Ojeda, A. V., Alsop, E. B., Martinez, M. N., Sharma, R., Hunsar, M., et al. (2025) · Journal of Extracellular Biology · doi:10.1002/jex2.70095 · Cited by 4
Sauerzopf, U., Sacco, R., Novarino, G., Niello, M., Weidenauer, A., Praschak-Rieder, N., Sitte, H. H., & Willeit, M. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13418 · Cited by 4
Paying the Toll in Nuclear Reprogramming
Liu, C., Himmati, F., & Sayed, N. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00070 · Cited by 4
Stem Cell Therapies for Cervical Spinal Cord Injury
Doulames, V. M., Marquardt, L. M., Jayaram, B., Plant, C. D., & Plant, G. W. (2016) · InTech eBooks · doi:10.5772/63580 · Cited by 4
Stem Cell Therapies for Neurodegenerative Diseases: Emerging Frontiers in Regenerative Medicine
Khedr, A. A., Abdelmaguid, A. M., Elshekh, A. H. A., El-Hanfy, S. A., Elmahdy, M. M., Hany, T., Mostafa, M. A., Elsakkary, N. W., Nabil, A., Mohsen, M., et al. (2025) · Frontiers in Scientific Research and Technology · doi:10.21608/fsrt.2025.424220.1180 · Cited by 3
Chung, T. D. Y., Khosla, S., Badley, A. D., & Jackson, M. R. C. (2014) · Wiley eBooks · doi:10.1002/9781118778166.ch27 · Cited by 3
Kandasamy, M., Yesudhas, A., Abirami, G. P. P., Radhakrishnan, R. K., Roshan, S. A., Johnson, E., Ravichandran, V. R., Biswas, A., Sellathamby, S., Anusuyadevi, M., et al. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.04.006 · Cited by 3
Human in vitro disease models to aid pathway and target discovery for neurological disorders
Muralidharan, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821972-0.00013-7 · Cited by 2
Proteomics and Schizophrenia: The Evolution of a Great Partnership
Smith, B. J., Carregari, V. C., & Martins‐de‐Souza, D. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-97182-3_10 · Cited by 2
Treatment of Neurodegenerative Diseases with Using of Stem Cells/Scaffolds
Eyni, H. (2016) · MOJ Anatomy & Physiology · doi:10.15406/mojap.2016.02.00065 · Cited by 2
Considerations in the Development of Pluripotent Stem Cell-based Therapies
Nasis, R., Cunningham, J. J., Brandon, E. P., & Cavagnaro, J. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394810-6.00015-0 · Cited by 2
Análise in vitro da esclerose lateral amiotrófica tipo 8 e estudo genético da paraplegia espástica 4
Mitne‐Neto, M. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2011.tde-24052011-112414 · Cited by 2
Baine, F. (2010) · Open University of Cape Town (University of Cape Town) · Cited by 2
Differentiation of Human Pluripotent Stem Cells into Cortical Neurons
Carromeu, C., Vessoni, A. T., Mendes, A. P. D., & Beltrão-Braga, P. C. B. (2016) · Springer eBooks · doi:10.1007/978-3-319-30582-0_10 · Cited by 1
Cellular and Animal Models of Neurologic Disease
Rangasamy, S., Narayanan, M. J., Schrauwen, I., Muotri, A. R., & Narayanan, V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-37101-8.00016-3 · Cited by 1
Synaptogenesis in the Adult CNS–Olfactory System
Mizrahi, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397266-8.00112-5 · Cited by 1
Nanoengineering of stem cells for neural regenerative medicine
Altuntaş, E., Gözütok, K., & Özkan, B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820223-4.00006-1 · Cited by 1
Inducible Pluripotent Stem Cells In Autism Spectrum Disorders
Muotri, A. R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391924-3.00028-4 · Cited by 1
Induced pluripotent stem-cell-derived models of sporadic and familial Alzheimer's disease
Israel, M. A. (2011) · eScholarship (California Digital Library)
Vessoni, A. T. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2015.tde-06102015-200543
Genome Engineering Technology and Its Application in Mammalian Cells
Cong, L. (2014) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Human iPSC Models: A Platform for Investigating Neurodevelopmental Diseases
McKinney, C. E. (2014) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000122
Determining the Role of Sonic Hedgehog in Establishing Midbrain Dopaminergic Neuron Subclasses
Kabanova, A. (2013) · bonndoc (University of Bonn)
Kim, H. J. (2014) · eScholarship (California Digital Library)
Atashpazgargari, S. (2015) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/atashpazgargari-sina_phd2015-03-18
Epilogue: Perspectives and Caveats
Roubertoux, P. L. (2014) · Neuromethods · doi:10.1007/978-1-4939-2250-5_19
Tsai, Y.-H. (2014) · eScholarship (California Digital Library)
Glaser, T. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2016.tde-07042016-084131
Melo, T. Q. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-01032017-131637
Oh, H. (2013) · TSpace (University of Toronto) · Cited by 1
Motor Neuron-Related Disorders
Li, L., Liu, Z., Chen, W., Wang, H., Li, H., & Chen, S. (2017) · Springer eBooks · doi:10.1007/978-981-10-4196-9_3
Rett Syndrome Induced Pluripotent Stem Cell-derived Neurons Exhibit Electrophysiological Aberrations
Farra, N. (2012) · TSpace (University of Toronto)
Marcuzzo, S., Bonanno, S., Barzago, C., D’Alessandro, S., Cavalcante, P., Galbardi, B., Malacarne, C., Taiana, M. M., Nizzardo, M., Corti, S. P., et al. (2018) · Journal of Translational Science · doi:10.15761/jts.1000247
Análise fenótipo-patogênica da infecção pelo vírus Zika em células humanas neurais in vitro
Cugola, F. R. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.10.2019.tde-05112018-154251
Avaliação da infecção do Zika vírus em astrócitos.
Ohki, C. M. Y. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2019.tde-09122021-110919
Roubertoux, P. L., & Carlier, M. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3777-6_5
Neuronal identity and maturation: insights from the single-cell transcriptome
van den Hurk, M. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20161213mh
Fan, G., & Huang, K. Y. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.6397956.6640054
Modeling Autism Spectrum Disorders Using Human Neurons
Muotri, A. R. (2013) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-36648-2_10
Faculty Opinions recommendation of Modeling autism spectrum disorders with human neurons.
Konopka, G. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726133421.793545854
Varderidou, S. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1458
Molecular Choreography of DNA: Insights and InnovationsPreprint
Odah, M. (2024) · Preprints.org · doi:10.20944/preprints202403.0393.v1
Unraveling the Causalities of Genetic Variations - Recent Advances in Cytogenetics
Okut, H., & Dey, S. K. (2024) · Genetics. · doi:10.5772/intechopen.111119
Considerations in the development of pluripotent stem cell–based therapies
Cunningham, J. J., Capela, A., Priest, C. A., & Brandon, E. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13344-2.00004-3
Qi, J., Qin, J., Gong, G., Song, B., Zhang, H., Wang, Y., Qi, H., Bi, Y., Zhang, Y., Xu, Y., et al. (2013)
Commercial Opportunities for Induced Pluripotent Stem Cells
Deusen, A. L. V., & Nasis, R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7696-2_13
Winnesberg, C. (2025) · Dokumentenrepositorium der RUB (Ruhr University Bochum) · doi:10.13154/294-13076
Apáti, Á. (2023) · REAL-d (Hungarian Academy of Sciences)
Unveiling CCBE1 role as a modulator of cardiomyocyte differentiation
Marques Silva, M. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
iPS Cell Models of Human Single Gene Inheritance Diseases
Ran, Y., & Guo, X. (2025) · Genetics. · doi:10.5772/intechopen.1006088
Melo, T. Q. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Glaser, T. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
The Role of Ribonucleotide Reductase in Inherited Purine Disorders
Tsui, M. (2022) · TSpace (University of Toronto)
Metadata
- Authors
- Marchetto, M. C. N., Winner, B., & Gage, F. H.
- Affiliations
- Salk Institute for Biological Studies (US)
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-15
- Volume
- 19
- Issue
- R1
- Pages
- R71-R76
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC2875052
- OpenAlex
- W2167639593
- Cited by
- 152
- References
- 85
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 8 · 2018: 7 · 2017: 7 · 2016: 21 · 2015: 9 · 2014: 14 · 2013: 23 · 2012: 14
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Human Molecular Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Christopher and Dana Reeve Foundation
- Alexander von Humboldt-Stiftung
- California Institute of Regenerative Medicine
- G. Harold and Leila Y. Mathers Foundation
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- induced pluripotent stem cells, disease modeling, neurodegenerative diseases, neurodevelopmental disorders, spinal muscular atrophy, familial dysautonomia, Parkinson's disease, amyotrophic lateral sclerosis, in vitro disease model, drug discovery
- MeSH terms
- Drug Evaluation, Preclinical, Humans, Neurodegenerative Diseases, Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.